This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
New Data, Case Studies & Partners
September 10th-11th, 2025Boston Exhibition & Convention Center, USA

Charles Chase
VP, Technical Business Development at Asymchem
Speaker

Profile

Chuck currently holds the role of the Vice President of Technical Business Development at Asymchem. Before joining Asymchem, he served as Vice President of Pharmaceutical Development at Elicio Therapeutics and Senior Principal Scientist at Eisai Inc. With experience spanning over 25 years in Chemistry, Manufacturing, and Controls (CMC), he possesses a deep understanding of process research and development across various substances, including oligonucleotides, peptides, and complex small molecules like Halaven®. His expertise encompasses synthesis, route optimization, CMC/CDMO management, and navigating regulatory approval processes.

Agenda Sessions

  • Fragment Based Ligation for Rapid Oligonucleotide Synthesis

    3:00pm